ReviewJournal of clinical medicine2025

Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis.

Georgiana-Diana Cazac-Panaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.